Two Sigma Advisers’s Lineage Cell Therapeutics LCTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$13.2K Sell
14,500
-208,864
-94% -$190K ﹤0.01% 2293
2025
Q1
$101K Buy
223,364
+136,400
+157% +$61.6K ﹤0.01% 2241
2024
Q4
$43.7K Buy
86,964
+65,864
+312% +$33.1K ﹤0.01% 2292
2024
Q3
$19.1K Sell
21,100
-1,400
-6% -$1.27K ﹤0.01% 2253
2024
Q2
$22.4K Sell
22,500
-9,900
-31% -$9.87K ﹤0.01% 2398
2024
Q1
$48K Sell
32,400
-5,500
-15% -$8.14K ﹤0.01% 2351
2023
Q4
$41.3K Sell
37,900
-1,200
-3% -$1.31K ﹤0.01% 2412
2023
Q3
$46.1K Sell
39,100
-10,499
-21% -$12.4K ﹤0.01% 2282
2023
Q2
$69.9K Sell
49,599
-17,500
-26% -$24.7K ﹤0.01% 2243
2023
Q1
$101K Sell
67,099
-22,064
-25% -$33.1K ﹤0.01% 2385
2022
Q4
$104K Sell
89,163
-130,900
-59% -$153K ﹤0.01% 2291
2022
Q3
$249K Sell
220,063
-43,003
-16% -$48.7K ﹤0.01% 2134
2022
Q2
$416K Sell
263,066
-352,700
-57% -$558K ﹤0.01% 2001
2022
Q1
$948K Sell
615,766
-474,600
-44% -$731K ﹤0.01% 1665
2021
Q4
$2.67M Sell
1,090,366
-22,000
-2% -$53.9K 0.01% 1049
2021
Q3
$2.8M Sell
1,112,366
-712,200
-39% -$1.79M 0.01% 1069
2021
Q2
$5.2M Buy
1,824,566
+190,700
+12% +$543K 0.01% 851
2021
Q1
$3.84M Buy
1,633,866
+1,124,000
+220% +$2.64M 0.01% 967
2020
Q4
$897K Buy
509,866
+172,200
+51% +$303K ﹤0.01% 1608
2020
Q3
$316K Buy
337,666
+45,900
+16% +$43K ﹤0.01% 1991
2020
Q2
$254K Buy
291,766
+58,200
+25% +$50.7K ﹤0.01% 2183
2020
Q1
$193K Sell
233,566
-12,800
-5% -$10.6K ﹤0.01% 2179
2019
Q4
$219K Buy
246,366
+58,400
+31% +$51.9K ﹤0.01% 2156
2019
Q3
$184K Buy
187,966
+17,977
+11% +$17.6K ﹤0.01% 2057
2019
Q2
$187K Buy
169,989
+28,300
+20% +$31.1K ﹤0.01% 2144
2019
Q1
$186K Sell
141,689
-12,564
-8% -$16.5K ﹤0.01% 2129
2018
Q4
$141K Buy
154,253
+57,838
+60% +$52.9K ﹤0.01% 2188
2018
Q3
$198K Sell
96,415
-10,745
-10% -$22.1K ﹤0.01% 2086
2018
Q2
$193K Buy
107,160
+36,005
+51% +$64.8K ﹤0.01% 2205
2018
Q1
$167K Sell
71,155
-31,776
-31% -$74.6K ﹤0.01% 2168
2017
Q4
$194K Buy
102,931
+83,214
+422% +$157K ﹤0.01% 2093
2017
Q3
$49K Buy
19,717
+4,458
+29% +$11.1K ﹤0.01% 2152
2017
Q2
$42K Buy
+15,259
New +$42K ﹤0.01% 2216
2017
Q1
Sell
-11,659
Closed -$37K 2409
2016
Q4
$37K Sell
11,659
-2,171
-16% -$6.89K ﹤0.01% 2305
2016
Q3
$47K Buy
+13,830
New +$47K ﹤0.01% 2177